Page 128«..1020..127128129130..140150..»

The Evolution of Godless Practices: Eugenics, Infanticide, and …

Posted: December 10, 2022 at 12:43 am

Commentary

There is a straight line that runs from eugenics through infanticide to transhumanism. All three are the devils work in the material world.

Let us explore the issue.

From biblical times to the present, there has been an ongoing battle between good and evil that has been waged. On one side, there are those who believe in a higher power and that mankind was made in the image of God, which is an immutable constant not to be trifled with or corrupted by human beings. Another way of saying that is that people in this camp believe that human nature itself has been immutable and constant through the millennia and that only by looking to God can mankind improve their condition.

On the other side are those who deny the existence of God. They believe that mankind is the supreme intelligence in control of human destiny, is malleable and can be shaped through science, and can evolve to a superior form of man through planning and experimentation by natural leaders over time. Therefore, in their view, there are no moral or religious constraints on the practices intended to evolve mankind toward some conceivedand ever-changingvision of the future.

Many in the first camp would characterize the ongoing battle as good versus evil. Mankind has been arguing about, defining, and redefining what it means to be good for millennia. The ancients defined good in terms of normal versus different, knowledge versus ignorance, and later right versus wrong in the context of defining laws and justice. Societies and governments were organized around these concepts.

The concept of evil has also been defined by many cultures through the ages. The dictionary now defines evil as morally wrong or bad; immoral; wicked. Most Americans (and most people in general) have an innate understanding of what is evil on a personal level. Some refer to that understanding as a conscience. Even the people in the second camp who believe that mankind is the supreme being may have consciences informed by religion and experience.

Governments have been organized to reflect, monitor, and control the cultural norms of the people governed. Logic dictates that those governments would also implement and enforce those cultural norms from a different philosophical framework from each other, partly as shaped by their respective religious philosophies and the various ideologies that have been developed and tested over the centuries, such as monarchical rule, Marxism, fascism, socialism, communism, corporate capitalism, patriarchy, oligarchy, philosopher kings, and so on.

The totalitarian ideologies that were developed and tested during the 20th century (particularly fascism and communism) denied the existence of God so that the governments that exercised those ideologies would be unconstrained by religious and moral boundaries in their pursuit of developing and grooming their version of modern man in their societies.

Examples of those perversions of mankind include the following:

The Nazis were obsessed with racial theories that resulted in a pseudoscientific racial classification system in which Aryans (people of German and Nordic descent) were considered to be the master race, at the apex of the human pyramid and destined to rule the world (on Nazi terms, of course). Jews were considered by Nazis to be on the lowest level of the hierarchy.

Nazi society was organized around these concepts in order to develop and promote those with the purest Aryan blood at the expense of those with lesser classifications in the hierarchy. For example, German boys were educated, inculcated, and groomed in Nazi principles through the Hitler Youth program. Girls were brainwashed through two parallel programs: Young Girls was an organization for girls aged 10 to 14, while the League of German Girls was for girls aged 14 to 18, with the latter being focused on comradeship, domestic duties, and motherhood.

The Soviet Man was to be the ultimate proof that communism worked and that mankind could evolve for the better (as defined by the communists) without Gods guidance. The Russian communists attempted to shape individual consciousness, character, and social practices in order to get the people to conform to the Marxist view of the perfect citizen.

The Soviets experimented with telepathic research, cybernetic simulations, and mass hypnotism over television to control the minds of their citizenry. This was a forerunner of the mass formation psychosis being exploited by the left and globalists these days.

The Chinese Communist Party (CCP) has controlled education in China for decades to politically indoctrinate students at all levels according to CCP ideology, principles, history, racial theories, and global objectives, and, most importantly, to condition everyone to acquiesce to the CCPs control of all aspects of Chinese society.

CCP leader Xi Jinping said in 2019, We need to strengthen political guidance for young people, guide them to voluntarily insist on the Partys leadership, to listen to the Party and follow the Party.

And the CCP is leading the world in implementing social controls to monitor all Chinese citizens compliance with CCP directives. Educate, monitor, control, and discipline: the perfect world with perfectly compliant citizens envisioned for all by the Chinese communists.

Theories initiated in the 19th century bore spoiled fruit in the 20th and 21st centuries. Karl Marxs theories (Marxism) begat the Communist Manifesto, whose godless adherents continue to plague the world today. Charles Darwins theory of evolution begat eugenics, which the National Institutes of Healths Genome Research Institute defines as an immoral and pseudoscientific theory that claims it is possible to perfect people and groups through genetics and the scientific laws of inheritance. John Deweys theory of progressive education similarly haunts U.S. public education to this very day.

Eugenics was and is particularly evil. Its adherents included the Nazis, Americans associated with the Population Society, the Committee on Eugenicswhich studied selective and restrictive human breedingand the American Eugenics Society.

Former President Franklin D. Roosevelt even promoted Nazi sympathizer and eugenicist Frederick Osborn to positions in government, including chairman of the Civilian Advisory Committee on Selective Service, chairman of the Army Committee on Welfare and Recreation, and chief of the Morale Branch of the War Department.

The Nazis used eugenics to justify the sterilization and, ultimately, elimination of undesirables, including Jews, homosexuals, gypsies, Slavs, and others. Eugenics theories led directly to the Nazi genocide that killed millions in Europe in the 1930s and 1940s.

Eugenics was also the basis for implementing sterilization laws in the United States in more than 30 states, with some of those laws persisting until the 1980s, according to the NIH Genome Research Institute. More than 60,000 people deemed to be idiots, imbeciles, promiscuous (females), or feebleminded were sterilized in the United States in the 20th century.

Eugenics also heavily influenced Margaret Sanger. A eugenicist and racist, Sanger founded the Birth Control League (1921) and its successor, Planned Parenthood (1942). She supported several eugenics initiatives: sterilization of people with mental and physical disabilities, segregation of undesirable criminals (for example, prostitutes, paupers, drug addicts, and the unemployed) into concentration camps, and mandatory birth control training for mothers with serious disease (choice was not part of the equation).

Another of Sangers initiatives was the Negro Project, in which predominantly black neighborhoods were targeted for birth control programs. Its purpose was evident, as she later disclosed in a private letter in December 1939: We dont want word to go out that we want to exterminate the Negro population.

Planned Parenthood was, of course, one of the main organizations behind the passage of Roe v. Wade in 1973. The Supreme Court decision claimed that a womans right to an abortion was implicit in the right to privacy protected by the 14th Amendment of the Constitution. As a selling point, its advocates first claimed that abortions should only be performed in rare instancesfor pregnancies resulting from rape or incest, or to save the mothers life.

Once the federal government funded Planned Parenthoods abortion clinics, abortion advocates incentivized by federal money pushed the boundaries of acceptable abortions from within the first trimester to eventually the evil practice of partial-birth abortions, in which a child being birthed is halted halfway and killed with scissors to the neck. Thus, simple therapeutic abortions have evolved into infanticidethe barbaric killing of children.

It should be noted that Adolf Hitlers Nazis were rightfully accused of committing genocide by killing 6 million Jews during the Holocaust. However, these numbers pale in comparison to the 63 million children aborted in the United States since the passage of Roe v. Wade in 1973. That number includes over 19 million black babies aborted. That is real genocide, the underpinning philosophy of which is evil. Eugenics has become infanticide.

The newest effort by the godless camp to meddle with the natural course of humanity is the transhumanism movement, which seeks to accelerate human evolution through advanced technologies. It is a segue from eugenics because it aims to enhance the human species through the addition of advanced biological and physical (mechanical, biomechanical) technologies or, as Britannica puts it, to augment or increase human sensory reception, emotive ability, or cognitive capacity as well as radically improve human health and extend human life spans.

In short, the goal is to create super-humans who will live forever. Just like eugenics, there is no natural selection involved, but rather a selective implementation by and for those willing to pay the cost (and to be experimented upon). And there is no limit to the experimentation and no ethical constraints on applying the technologies.

God versus man. Good versus evil. The eternal struggle.

First came eugenics, then came abortion on demand and infanticide, and now there is the new horizon posed by transhumanism. That is the evolution of an evil kind! None of these have moral, ethical, or religious constraintsall are arbitrary, determined by those holding political power.

The Biden administration has cleared the decks for transhumanism by signing the Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy on Sept. 12. Into the Brave New World we gowith much trepidation!

Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times.

Follow

Stu Cvrk retired as a captain after serving 30 years in the U.S. Navy in a variety of active and reserve capacities, with considerable operational experience in the Middle East and the Western Pacific. Through education and experience as an oceanographer and systems analyst, Cvrk is a graduate of the U.S. Naval Academy, where he received a classical liberal education that serves as the key foundation for his political commentary.

Read more here:
The Evolution of Godless Practices: Eugenics, Infanticide, and ...

Posted in Transhumanism | Comments Off on The Evolution of Godless Practices: Eugenics, Infanticide, and …

Ancient Wisdom in Medicine / AI & Transhumanism | Coast to Coast AM

Posted: December 10, 2022 at 12:43 am

In the first half, Dr. Stephen G. Post discussed RED (remembered experiences of death), Alzheimer's disease, and acts of love and kindness. He discussed the nature and treatment of Alzheimer's disease, including the positive results that love and kindness toward Alzheimer's patients can bring. Such an approach isn't new in caring for the sick, he maintained, but draws upon ancient wisdom that love heals.

Science has recently begun to embrace the phenomenon of near-death experience, said Post, citing the attention NDEs have been getting in professional literature and at conferences. Emerging evidence suggests that NDEs are often accompanied by RED: remembered experiences of death. Post finds this progress encouraging, he noted, because it lends empirical credibility to what amounts to spiritual wisdom that's been around for much of human history.

**********************

Author and researcher Patricia Cori was the guest in the second half. She warned of the dangers of advanced artificial intelligence, particularly its potential effect on individual freedom and autonomy. In the most dangerous scenario, she explained, the result would be transhumanism: widespread control of the human mind and body by programmable technology. Although she acknowledged that certain limited forms of AI have been beneficial for humanity, in Cori's view we have passed the tipping point between benefit and harm and are now in "runaway mode," heading toward an inevitable singularity where AI overrides human consciousness and natural human evolution. The perpetrators of these efforts include a clandestine alien race intent on destroying us, Big Pharma, governments, Bill Gates, world economic leaders, and the United Nations, she continued. And we don't have much time to act, argued Cori: the goal of those seeking to implement transhumanism is 2030.

Cori offered several examples of the runaway AI on the agenda. The implanting of microchips into human brains is in the works, she claimed, as well as body activity sensors that provide financial incentives. The chipping of our pets is a test run for using the technology as on people as well, which will result in widespread use of microchips being implanted into our own bodies. Pills and injected vaccinations that contain tiny DNA-controlling devices are also on the way, Cori warned.

Despite her fears, Cori expressed optimism that our species will ultimately rebel against this kind of encroachment on our humanity. The key, she asserted, is convincing others that the situation is dire enough to act.

News Segment guests: Howard Bloom / Mish Shedlock

Follow this link:
Ancient Wisdom in Medicine / AI & Transhumanism | Coast to Coast AM

Posted in Transhumanism | Comments Off on Ancient Wisdom in Medicine / AI & Transhumanism | Coast to Coast AM

Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers – Scientific American

Posted: December 10, 2022 at 12:40 am

Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers  Scientific American

More:
Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers - Scientific American

Posted in Genetics | Comments Off on Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers – Scientific American

Ethical issues in stem cell research and therapy

Posted: December 10, 2022 at 12:27 am

Lo B, Parham L: Resolving ethical issues in stem cell clinical trials: the example of Parkinson disease. J Law Med Ethics. 2010, 38: 257-266. 10.1111/j.1748-720X.2010.00486.x.

Article PubMed Google Scholar

Habets MG, van Delden JJ, Bredenoord AL: The inherent ethical challenge of first-in-human pluripotent stem cell trials. Regen Med. 2014, 9: 1-3. 10.2217/rme.13.83.

Article CAS PubMed Google Scholar

Niemansburg SL, Teraa M, Hesam H, van Delden JJ, Verhaar MC, Bredenoord AL: Stem cell trials for cardiovascular medicine: ethical rationale. Tiss Eng Part A. 2013, [Epub ahead of print]

Google Scholar

Levine R: Ethics and Regulation of Clinical Research. 1988, New York: Yale University Press

Google Scholar

Gilbert S, Kaebnick GE, Murray TH: Special Report: Animal research ethics: evolving views and practices. Hastings Center Rep. 2012, 42: S1-S39.

Article Google Scholar

Joffe S, Miller FG: Bench to bedside: mapping the moral terrain of clinical research. Hastings Center Rep. 2008, 38: 30-42.

Article Google Scholar

Arcidiacono JA, Blair JW, Benton KA: US Food and Drug Administration international collaborations for cellular therapy product regulation. Stem Cell Res Ther. 2012, 3: 38-42. 10.1186/scrt129.

Article PubMed Central PubMed Google Scholar

Caulfield T, Zarzeczny A, McCormick J, Bubela T, Critchley C, Einsiedel E, Galipeau J, Harmon S, Huynh M, Hyun I, Illes J, Isasi R, Joly Y, Laurie G, Lomax G, Longstaff H, McDonald M, Murdoch C, Ogbogu U, Owen-Smith J, Pattinson S, Premji S, von Tigerstrom B, Winickoff DE: The stem cell research environment: a patchwork of patchworks. Stem Cell Rev. 2009, 5: 82-88. 10.1007/s12015-009-9071-3.

Article PubMed Google Scholar

Greely H: Assessing ESCROs: yesterday and tomorrow. Am J Bioeth. 2013, 13: 44-52.

Article PubMed Google Scholar

Lomax GP, Peckman SR: Stem cell policy exceptionalism: proceed with caution. Stem Cell Rev Rep. 2012, 8: 299-304. 10.1007/s12015-011-9305-z.

Article Google Scholar

Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermeren G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ: New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell. 2008, 3: 607-609. 10.1016/j.stem.2008.11.009.

Article CAS PubMed Google Scholar

International Society for Stem Cell Research: Guidelines for the clinical translation of stem cells. [http://www.isscr.org/docs/guidelines/isscrglclinicaltrans.pdf]

Caulfield T: Stem cell research and economic promises. J Law Med Ethics. 2010, 38: 303-313. 10.1111/j.1748-720X.2010.00490.x.

Article PubMed Google Scholar

Caulfield T, Rachul C, Zarzeczny A: The evolution of policy issues in stem cell research: an international survey. Stem Cell Rev Rep. 2012, 8: 1037-1042. 10.1007/s12015-012-9404-5.

Article Google Scholar

Emanuel EJ, Wendler D, Grady C: What makes clinical research ethical?. JAMA. 2000, 283: 2701-2711. 10.1001/jama.283.20.2701.

Article CAS PubMed Google Scholar

Kato K, Kimmelman J, Robert J, Sipp D, Sugarman J: Ethical and policy issues in the clinical translation of stem cells: report of a focus session at the ISSCR annual meeting. Cell Stem Cell. 2012, 11: 765-767. 10.1016/j.stem.2012.11.004.

Article CAS PubMed Google Scholar

London AJ, Kimmelman J, Emborg ME: Beyond access vs. protection in trials of innovative therapies. Science. 2010, 328: 829-830. 10.1126/science.1189369.

Article PubMed Central CAS PubMed Google Scholar

King NM, Cohen-Haguenauer O: En route to ethical recommendations for gene transfer clinical trials. Mol Ther. 2008, 16: 432-438. 10.1038/mt.2008.13.

Article CAS PubMed Google Scholar

Dresser R: First-in-human trial participants: not a vulnerable population, but vulnerable nonetheless. J Law Med Ethics. 2009, 37: 38-50.

Article PubMed Central PubMed Google Scholar

Dresser R: Stem cell research as innovation: expanding the ethical and policy conversation. J Law Med Ethics. 2010, 38: 332-341. 10.1111/j.1748-720X.2010.00492.x.

Article PubMed Central PubMed Google Scholar

Dresser R: Alive and well: the research imperative. J Law Med Ethics. 2012, 40: 915-921.

Article PubMed Google Scholar

Dresser R: The ubiquity and utility of the therapeutic misconception. Soc Philos Policy. 2002, 19: 271-294. 10.1017/S0265052502192119.

Article PubMed Google Scholar

King NM, Henderson GE, Churchill LR, Davis AM, Hull SC, Nelson DK, Parham-Vetter PC, Rothschild BB, Easter MM, Wilfond BS: Consent forms and the therapeutic misconception: the example of gene transfer research. IRB. 2005, 27: 1-

Article PubMed Google Scholar

Hyun I: The bioethics of stem cell research and therapy. J Clin Invest. 2010, 120: 71-75. 10.1172/JCI40435.

Article PubMed Central CAS PubMed Google Scholar

Daley GQ: The promise and perils of stem cell therapeutics. Cell Stem Cell. 2012, 10: 740-749. 10.1016/j.stem.2012.05.010.

Article PubMed Central CAS PubMed Google Scholar

Sugarman J: Human stem cell ethics: beyond the embryo. Cell Stem Cell. 2008, 2: 529-533. 10.1016/j.stem.2008.05.005.

Article CAS PubMed Google Scholar

Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research: Guidance for industry: considerations for the design and conduct of early-phase clinical trials of cellular and gene therapy products (DRAFT). 2013, [http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/UCM359073.pdf]

Google Scholar

Sipp D: Direct-to-consumer stem cell marketing and regulatory responses. Stem Cells Translational Med. 2013, 2: 638-640. 10.5966/sctm.2013-0040.

Article Google Scholar

Weissman I: Stem cell therapies could change medicine if they get the chance. Cell Stem Cell. 2012, 10: 663-665. 10.1016/j.stem.2012.05.014.

Article CAS PubMed Google Scholar

Hyun I, Hochedlinger K, Jaenish R, Yamanaka S: New advances in iPS cell research do not obviate the need for human embryonic stem cells. Cell Stem Cell. 2007, 4: 367-368.

Article Google Scholar

King NM, Coughlin CN, Atala A: Pluripotent stem cells: the search for the perfect source. Minn J Law Sci Technol. 2011, 12: 715-730.

Google Scholar

Ishii T, Pera RA, Greely HT: Ethical and legal issues arising in research on inducing human germ cells from pluripotent stem cells. Cell Stem Cell. 2013, 13: 145-148. 10.1016/j.stem.2013.07.005.

Article CAS PubMed Google Scholar

Cohen CB: Renewing the Stuff of Life: Stem Cells, Ethics, and Public Policy. 2007, New York: Oxford University Press

Google Scholar

Human Embryonic Stem Cell Research Advisory Committee, The National Academies: Final Report and 2010 Amendments to the National Academies Guidelines for Human Embryonic Stem Cell Research. 2010, Washington, DC: National Academies Press

Google Scholar

Yamanaka S: Induced pluripotent stem cells: past, present, and future. Cell Stem Cell. 2012, 10: 678-684. 10.1016/j.stem.2012.05.005.

Article CAS PubMed Google Scholar

Pera MF: Stem cells: the dark side of induced pluripotency. Nature. 2011, 471: 46-47. 10.1038/471046a.

Article CAS PubMed Google Scholar

Obokata H, Wakayama T, Sasai Y, Kojima K, Vacanti MP, Niwa H, Yamato M, Vacanti CA: Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature. 2014, 505: 641-647. 10.1038/nature12968.

Article CAS PubMed Google Scholar

Cyranoski D: Acid bath offers easy path to stem cells. Nature. 2014, 505: 596-10.1038/505596a.

Article CAS PubMed Google Scholar

Cyranoski D: Acid-bath stem-cell study under investigation. Nature. 2014, [http://www.nature.com/news/acid-bath-stem-cell-study-under-investigation-1.14738]

Google Scholar

Kimmelman J, Baylis F, Glass KG: Stem cell trials: lessons from gene transfer research. Hastings Cent Rep. 2006, 36: 23-26.

Article PubMed Google Scholar

Hyun I: Allowing innovative stem cell based therapies outside of clinical trials: ethical and policy challenges. J Law Med Ethics. 2010, 38: 277-285. 10.1111/j.1748-720X.2010.00488.x.

Article PubMed Google Scholar

Wilson JM: A history lesson for stem cells. Science. 2009, 324: 727-728. 10.1126/science.1174935.

Article CAS PubMed Google Scholar

Bretzner F, Gilbert F, Baylis F, Brownstone RM: Target populations for first-in-human embryonic stem cell research in spinal cords. Cell Stem Cell. 2011, 8: 468-475. 10.1016/j.stem.2011.04.012.

Article CAS PubMed Google Scholar

Lukovic D, Stojkovic M, Moreno-Manzano V, Bhattacharya SS, Erceg S: Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Gerons clinical trial for spinal cord injury. Stem Cells Dev. 2014, 23: 1-4. 10.1089/scd.2013.0266.

Article PubMed Google Scholar

Illes J, Reimer C, Kwon BK: Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition. Stem Cell Rev. 2011, 7: 997-1005. 10.1007/s12015-011-9259-1.

Article CAS PubMed Google Scholar

Esch MB, King TL, Shuler ML: The role of body-on-a-chip devices in drug and toxicity studies. Ann Rev Biomed Eng. 2011, 13: 55-72. 10.1146/annurev-bioeng-071910-124629.

Article CAS Google Scholar

Lowenthal J, Lipnick S, Rao M, Hull SC: Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent. Stem Cells Translational Med. 2012, 1: 409-421. 10.5966/sctm.2012-0029.

Article Google Scholar

Lomax GP, Hull SC, Lowenthal J, Rao M, Isasi R: The DISCUSS project: induced pluripotent stem cell lines from previously collected research biospecimens and informed consent: points to consider. Stem Cells Translational Med. 2013, 2: 727-730. 10.5966/sctm.2013-0099.

Article Google Scholar

Lomax GP, Shepard KA: Return of results in translational iPS cell research: considerations for donor informed consent. Stem Cell Res Ther. 2013, 4: 6-7. 10.1186/scrt154.

Article PubMed Central PubMed Google Scholar

Hyun I: The bioethics of iPS cell based drug discovery. Clin Pharmacol Ther. 2011, 89: 646-647. 10.1038/clpt.2010.308.

Article CAS PubMed Google Scholar

King NM, Coughlin CN, Furth M: Ethical issues in regenerative medicine. Wake Forest Intellectual Property Law J. 2009, 9: 216-238.

Excerpt from:
Ethical issues in stem cell research and therapy

Posted in Stem Cell Therapy | Comments Off on Ethical issues in stem cell research and therapy

Trends in Molecular Medicine | Journal – ScienceDirect

Posted: December 10, 2022 at 12:24 am

Trends in Molecular Medicine objective is to provide concise and contextualized views on the latest research moving biomedical science closer to improved diagnosis, treatment, and prevention of human diseases. As such, TMM is dedicated to research disciplines at the interface between basic biology and clinical research. Articles cover new concepts in mechanisms of human biology and pathology with clear implications for diagnostics and therapy. Bridging bench and bedside, reviews published in TMM have clear implications for human health and disease and discuss not only preclinical studies but also research conducted on patient samples, first-in-man studies, and patient-enrolled trials. The major themes covered in TMM in include:Disease mechanismsTools and technologiesDiagnosticsTherapeutics

We particularly seek articles that are relevant to more than one of these themes. The goal of TMM is to serve as platform for discussion, push the boundaries of traditional clinical or scientific categorization and forge new links between scientists and clinicians. TMM reviews and opinions serve as templates for future explorations in molecular medicine, and to inspire new directions of studies toward improving human health. The journal?s focus is on publishing articles that are provocative and authoritative but also accessible to a broad audience.

Furthermore 'medicine' involves a vital societal element; molecular interventions raise controversial ethical, legal and financial issues. TMM also publishes discussions concerning the clinical trial landscape, science policy and medical ethics.

All these issues are addressed in TMM in a style that builds on 25 years' experience of publishing the Trends journals.

For more information, go to http://www.cell.com/trends/molecular-medicine

Trends in Molecular Medicine objective is to provide concise and contextualized views on the latest research moving biomedical science closer to improved diagnosis, treatment, and prevention of human diseases. As such, TMM is dedicated to research disciplines at the interface between basic biology

Original post:
Trends in Molecular Medicine | Journal - ScienceDirect

Posted in Molecular Medicine | Comments Off on Trends in Molecular Medicine | Journal – ScienceDirect

Gilead lands new cell therapy for Kite in $225M Arcellx deal, providing global scale for future J&J-Legend showdown – FierceBiotech

Posted: December 10, 2022 at 12:21 am

  1. Gilead lands new cell therapy for Kite in $225M Arcellx deal, providing global scale for future J&J-Legend showdown  FierceBiotech
  2. Gilead buys into multiple myeloma cell therapy with Arcellx deal  BioPharma Dive
  3. Gilead Sciences Gets a Shot at Next-Gen Cell Therapy With $325M Arcellx Alliance  MedCity News
  4. Kite and Arcellx Announce Strategic Collaboration to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma  Gilead Sciences
  5. Gilead Sciences' Kite, Arcellx to Develop, Commercialize Cell Therapy Treatment for Multiple Myeloma  Marketscreener.com
  6. View Full Coverage on Google News

More:
Gilead lands new cell therapy for Kite in $225M Arcellx deal, providing global scale for future J&J-Legend showdown - FierceBiotech

Posted in Cell Therapy | Comments Off on Gilead lands new cell therapy for Kite in $225M Arcellx deal, providing global scale for future J&J-Legend showdown – FierceBiotech

The Legacy of Henrietta Lacks – Hopkins Medicine

Posted: December 10, 2022 at 12:20 am

In 1951, a young mother of five named Henrietta Lacks visited The Johns Hopkins Hospital complaining of vaginal bleeding. Upon examination, renowned gynecologist Dr. Howard Jones discovered a large, malignant tumor on her cervix. At the time, The Johns Hopkins Hospital was one of only a few hospitals to treat poor African-Americans.

As medical records show, Mrs. Lacks began undergoing radium treatments for her cervical cancer. This was the best medical treatment available at the time for this terrible disease. A sample of her cancer cells retrieved during a biopsy were sent to Dr. George Gey's nearby tissue lab. For years, Dr. Gey, a prominent cancer and virus researcher, had been collecting cells from all patients - regardless of their race or socioeconomic status - who came to The Johns Hopkins Hospital with cervical cancer, but each sample quickly died in Dr. Geys lab. What Dr. Gey would soon discover was that Mrs. Lacks cells were unlike any of the others he had ever seen: where other cells would die, Mrs. Lacks' cells doubled every 20 to 24 hours.

Today, these incredible cells nicknamed "HeLa" cells, from the first two letters of her first and last names are used to study the effects of toxins, drugs, hormones and viruses on the growth of cancer cells without experimenting on humans. They have been used to test the effects of radiation and poisons, to study the human genome, to learn more about how viruses work, and played a crucial role in the development of the polio and COVID-19vaccines.

Although Mrs. Lacks ultimately passed away on October 4, 1951, at the age of 31, her cells continue to impact the world.

Although these were the first cells that could be easily shared and multiplied in a lab setting, Johns Hopkins has never sold or profited from the discovery or distribution of HeLa cells and does not own the rights to the HeLa cell line. Rather, Johns Hopkins offered HeLa cells freely and widely for scientific research.

Johns Hopkins applauds and regularly participates in efforts to raise awareness of the life and story of Henrietta Lacks. Having reviewed our interactions with Henrietta Lacks and with the Lacks family over more than 50 years, we found that Johns Hopkins could have and should have done more to inform and work with members of Henrietta Lacks family out of respect for them, their privacy and their personal interests. Though the collection and use of Henrietta Lacks cells in research was an acceptable and legal practice in the 1950s, such a practice would not happen today without the patients consent.

We are deeply committed to the ongoing efforts at our institutions and elsewhere to honor the contributions of Henrietta Lacks and to ensure the appropriate protection and care of the Lacks familys medical information.

Read the original:
The Legacy of Henrietta Lacks - Hopkins Medicine

Posted in Cell Medicine | Comments Off on The Legacy of Henrietta Lacks – Hopkins Medicine

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class, Route of Administration, and Segment Forecast, 2022-2027…

Posted: December 10, 2022 at 12:15 am

Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class, Route of Administration, and Segment Forecast, 2022-2027  Longview News-JournalView Full Coverage on Google News

Excerpt from:
Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class, Route of Administration, and Segment Forecast, 2022-2027...

Posted in Regenerative Medicine | Comments Off on Regenerative Medicine in Pharma Market Size, Share and Trends Analysis by Region, Drug Class, Route of Administration, and Segment Forecast, 2022-2027…

Where Does Omega Therapeutics Inc (OMGA) Stock Fall in the Biotechnology Field After It Has Fallen -1.56% This Week? – InvestorsObserver

Posted: December 10, 2022 at 12:12 am

Where Does Omega Therapeutics Inc (OMGA) Stock Fall in the Biotechnology Field After It Has Fallen -1.56% This Week?  InvestorsObserver

Visit link:
Where Does Omega Therapeutics Inc (OMGA) Stock Fall in the Biotechnology Field After It Has Fallen -1.56% This Week? - InvestorsObserver

Posted in Biotechnology | Comments Off on Where Does Omega Therapeutics Inc (OMGA) Stock Fall in the Biotechnology Field After It Has Fallen -1.56% This Week? – InvestorsObserver

Where Does Arcus Biosciences Inc (RCUS) Stock Fall in the Biotechnology Field After It Is Lower By -12.07% This Week? – InvestorsObserver

Posted: December 10, 2022 at 12:12 am

Where Does Arcus Biosciences Inc (RCUS) Stock Fall in the Biotechnology Field After It Is Lower By -12.07% This Week?  InvestorsObserver

Read more:
Where Does Arcus Biosciences Inc (RCUS) Stock Fall in the Biotechnology Field After It Is Lower By -12.07% This Week? - InvestorsObserver

Posted in Biotechnology | Comments Off on Where Does Arcus Biosciences Inc (RCUS) Stock Fall in the Biotechnology Field After It Is Lower By -12.07% This Week? – InvestorsObserver

Page 128«..1020..127128129130..140150..»